J Gastroenterol Hepatol Endosc | Volume 6, Issue 2 | Short Communication | Open Access
Jessica H Kim*, Jeffrey Quedado, Lisa Keller, Alexandra Greco, Sarah Mallow and John Nasr
WVU Hospitals, USA
*Correspondance to: Jessica H Kim
Fulltext PDFAim: The purpose of this study is to answer if re-visits to the hospital are similar between the uses of a Fluoroquinolone (FQ) or Non-Fluoroquinolone (NFQ) antibiotic regimen in the treatment of AUD.
Materials and Methods: This retrospective cohort study included adult patients managed with antibiotics in the Emergency Department (ED) or inpatient setting for AUD. The primary outcome evaluated the rate of re-visits to the ED or hospitalization for AUD within thirty days of discharge in patients who were initially managed with either a Fluoroquinolone (FQ) or Non-Fluoroquinolone (NFQ) antibiotic regimen.
Results: Rates of re-visit to the ED or re-admission within thirty days of discharge were not statistically significant in the FQ vs. NFQ groups [10% vs. 7%, p=0.45]. Duration of treatment in patients who had a re-visit also did not show statistical significance (p=0.44). The most common duration of treatment was five to ten days, which is the current treatment recommendation, based
on our institution’s guideline.
Conclusion: Based on the findings of this study, we concluded that no difference was found in revisits to the ED or inpatient setting for AUD within thirty days of discharge in patients who were managed with either a FQ or NFQ antibiotic regimen.
Kim JH, Quedado J, Keller L, Greco A, Mallow S, Nasr J. Evaluation of Fluoroquinolone vs. Non-Fluoroquinolone Treatment of Acute Uncomplicated Diverticulitis in a Large Academic Medical Center. J Gastroenterol Hepatol Endosc. 2021;6(2): 1096..